These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11855989)

  • 1. 6-Sulfonylchromenes as highly potent K(ATP)-channel openers.
    Salamon E; Mannhold R; Weber H; Lemoine H; Frank W
    J Med Chem; 2002 Feb; 45(5):1086-97. PubMed ID: 11855989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxant activity in rat aorta and trachea, conversion to a muscarinic receptor antagonist and structure-activity relationships of new K(ATP) activating 6-varied benzopyrans.
    Lemoine H; Weber H; Derix A; Uhrig U; Höltje HD; Mannhold R
    Eur J Pharmacol; 1999 Jul; 378(1):85-97. PubMed ID: 10478568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis.
    Mannhold R; Cruciani G; Weber H; Lemoine H; Derix A; Weichel C; Clementi M
    J Med Chem; 1999 Mar; 42(6):981-91. PubMed ID: 10090781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K(ATP)-channel openers.
    Carosati E; Lemoine H; Spogli R; Grittner D; Mannhold R; Tabarrini O; Sabatini S; Cecchetti V
    Bioorg Med Chem; 2005 Oct; 13(19):5581-91. PubMed ID: 16002299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
    Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
    J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
    Greenwood IA; Weston AH
    Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim.
    Sebille S; Gall D; de Tullio P; Florence X; Lebrun P; Pirotte B
    J Med Chem; 2006 Jul; 49(15):4690-7. PubMed ID: 16854075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
    Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
    Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioselective antiischemic ATP-sensitive potassium channel openers. 2. Structure-activity studies on benzopyranylcyanoguanidines: modification of the benzopyran ring.
    Atwal KS; Grover GJ; Ferrara FN; Ahmed SZ; Sleph PG; Dzwonczyk S; Normandin DE
    J Med Chem; 1995 May; 38(11):1966-73. PubMed ID: 7783128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a specific binding site for K+ channel openers in rat aorta.
    Ouast U; Bray KM; Baumlin Y; Andres H; Manley PW
    Jpn J Pharmacol; 1992; 58 Suppl 2():226P-231P. PubMed ID: 1507537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
    Quast U; Bray KM; Andres H; Manley PW; Baumlin Y; Dosogne J
    Mol Pharmacol; 1993 Mar; 43(3):474-81. PubMed ID: 8450836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization.
    Gopalakrishnan M; Buckner SA; Whiteaker KL; Shieh CC; Molinari EJ; Milicic I; Daza AV; Davis-Taber R; Scott VE; Sellers D; Chess-Williams R; Chapple CR; Liu Y; Liu D; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ
    J Pharmacol Exp Ther; 2002 Oct; 303(1):379-86. PubMed ID: 12235274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KATP channel openers: structure-activity relationships and therapeutic potential.
    Mannhold R
    Med Res Rev; 2004 Mar; 24(2):213-66. PubMed ID: 14705169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ATP-sensitive K+ channels by ATP and nucleotide diphosphate in rabbit portal vein.
    Kamouchi M; Kitamura K
    Am J Physiol; 1994 May; 266(5 Pt 2):H1687-98. PubMed ID: 8203568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
    de Tullio P; Becker B; Boverie S; Dabrowski M; Wahl P; Antoine MH; Somers F; Sebille S; Ouedraogo R; Hansen JB; Lebrun P; Pirotte B
    J Med Chem; 2003 Jul; 46(15):3342-53. PubMed ID: 12852765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitivity to ATP-sensitive potassium channel openers of norepinephrine-induced contraction of guinea pig and rat aorta.
    Saito W; Aida M; Sasaki M; Saito Y; Tanaka Y; Tanaka H; Shigenobu K
    Life Sci; 1998; 62(24):2171-9. PubMed ID: 9627075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
    Butera JA; Antane MM; Antane SA; Argentieri TM; Freeden C; Graceffa RF; Hirth BH; Jenkins D; Lennox JR; Matelan E; Norton NW; Quagliato D; Sheldon JH; Spinelli W; Warga D; Wojdan A; Woods M
    J Med Chem; 2000 Mar; 43(6):1187-202. PubMed ID: 10737752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
    Kwan YW; To KW; Lau WM; Tsang SH
    Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Original 2-alkylamino-6-halogenoquinazolin-4(3H)-ones and K(ATP) channel activity.
    Somers F; Ouedraogo R; Antoine MH; de Tullio P; Becker B; Fontaine J; Damas J; Dupont L; Rigo B; Delarge J; Lebrun P; Pirotte B
    J Med Chem; 2001 Aug; 44(16):2575-85. PubMed ID: 11472211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.